Category: News & Events

Effects of Scalene Muscle Stretching on Slow Vital Capacity and Chest Expansion in Patients After Coronary Artery Bypass Grafting: An Interventional Study

Announcing a new article publication for Cardiovascular Innovations and Applications journal.

Coronary artery bypass grafting (CABG) is a coronary revascularization technique associated with diminished pulmonary function. During the first week after CABG, slow vital capacity (SVC) decreases by 30%–60%. Scalene muscles affect pulmonary function because they attach to the 1st and 2nd ribs. Shorter scalene muscles can decrease inhalation volume and chest expansion. Very few studies have assessed the effects of scalene stretching on SVC and chest expansion in patients post-CABG. Therefore, this study was aimed at determining the effects of scalene muscle stretching on SVC and chest expansion in such patients.

A total of 74 patients post-CABG (phase 2) meeting the inclusion criteria were randomly allocated to two groups: an intervention group (n = 30) performing scalene muscle stretching and a control group (n = 30) performing active neck exercise. Pre & Post SVC and chest expansion were measured in all patients. A total of 14 patients were excluded. Statistical analysis was conducted in SPSS software (version 20.0).

SVC showed significant increase (P < 0.05) in the intervention group compared with the control group. Chest expansion was statistically non-significant between groups (P > 0.05).

Scalene muscle stretching improves SVC in patients post-CABG (phase 2). Hence, scalene stretching should be included in programs for improving respiratory function.

https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2023.0089

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Miral Vyas, Mihir Mehta and Falak Oza et al. Effects of Scalene Muscle Stretching on Slow Vital Capacity and Chest Expansion in Patients After Coronary Artery Bypass Grafting: An Interventional Study. CVIA. 2024. Vol. 9(1). DOI: 10.15212/CVIA.2023.0089

Loading

The Development of Ventricular Assist Devices over the Past 30 Years: A Bibliometric Analysis

Announcing a new article publication for Cardiovascular Innovations and Applications journal.

A large gap exists between the needs of patients with end-stage heart failure and the number of gold-standard heart transplants. Over the past 30 years, a revolutionary treatment strategy using ventricular assist devices (VADs) has rapidly developed and become widely used in clinical practice. However, few analyses have assessed the application and publication trends in the VAD field.

The authors of this article used the Web of Science core collection to identify VAD research published between 1992 and 2022. Analysis and data visualization was performed with CiteSpace, Scimago Graphica, and VOSviewer.

13,274 articles published in 1129 journals were identified, describing work from 6351 institutions in 86 countries. Among them, the United States contributed the most to VAD research, and almost all the top ten authors and institutions contributing to VAD research were from the United States.

In the past 5 years, VAD research has focused on right heart failure, outcomes, effects and risk factors, societies of surgeons, and clinical guidelines. Because of the large number of patients with heart failure, it is expected that VAD development to peak in the next decade.

https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2023.0088

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Zhou Liu, Siyue Zheng and Yazhe Zhang et al. The Development of Ventricular Assist Devices over the Past 30 Years: A Bibliometric Analysis. CVIA. 2024. Vol. 9(1). DOI: 10.15212/CVIA.2023.0088

Loading

Model for Patients with Multivessel Coronary Artery Lesions in the Highlands Region (Qinghai Province, Northwest China)

Announcing a new article publication for Cardiovascular Innovations and Applications journal.

The severity and prognosis of coronary artery disease are closely associated with treatment strategy choice. To achieve timely, accurate, early selection of a suitable treatment plan and assess patients’ prognosis, the authors of this article developed an effective predictive model for early identification of high-risk patients according to lesion severity.

Among the 510 patients with chest pain admitted to the Qinghai Red Cross Hospital between August 2018 and October 2019, 386 had coronary artery disease detected by coronary angiography. A total of 24 demographic characteristics and serum markers were analyzed in study participants. Least absolute shrinkage and selection operator regression was used to select variables, and multivariate logistic regression was used to build predictive models by using nominal plots. The discriminatory power of the models was evaluated with the area under the receiver operating characteristic curve (AUC). Predictive models were calibrated with calibration plots and the Hosmer–Lemeshow test. Their clinical validity was evaluated via decision curve analysis.

Data were randomly divided (7:3) into training (358 cases) and test (152 cases) sets. The predictive model included sex, age, smoking status, heart rate, systolic blood pressure, diastolic blood pressure, albumin, urea nitrogen, creatinine, uric acid, total cholesterol, and high-density lipoprotein cholesterol as predictors. The AUCs for the training and test sets were 0.793 and 0.732, respectively. The predictive model showed a good fit, and decision curve analysis indicated the clinical validity of the predictive model.

An effective risk predictive model was developed with good clinical value for predicting multivessel disease. Smoking cessation, lowering creatinine, and increasing HDL cholesterol concentrations might decrease the risk of developing multivessel disease, thereby avoiding severe disease.

https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2023.0084

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Jun Li, Haixia Qin and Jiuping Zhao et al. Model for Patients with Multivessel Coronary Artery Lesions in the Highlands Region (Qinghai Province, Northwest China). CVIA. 2024. Vol. 9(1). DOI: 10.15212/CVIA.2023.0084

Loading

Continuous Positive Airway Pressure Therapy and Long-Term Outcomes in Patients with Coronary Artery Disease and Obstructive Sleep Apnea: A Meta-Analysis of Randomized Trials

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Obstructive sleep apnea (OSA) is highly common in patients with coronary artery disease (CAD) and it is a strong predictor of subsequent cardiovascular events. However, whether treatment with continuous positive airway pressure (CPAP) can decrease this risk remains controversial.

PubMed, EMBASE, the Cochrane Library, and ClinicalTrials.gov were systematically searched to identify randomized clinical trials reporting cardiovascular events from database inception to February 12, 2022.

(more…)

Loading

Age-related Pancoronary Characteristics in Patients with ST-segment Elevation Myocardial Infarction

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Age-related vulnerable characteristics of pancoronary plaques in patients with ST-segment elevation myocardial infarction (STEMI) have not been systemically evaluated by optical coherence tomography (OCT). The authors of this article explore the discrepancies in pancoronary characteristics between younger and older patients with STEMI through OCT.

This retrospective single-center study included 588 patients who had STEMI and underwent three-vessel OCT through emergency percutaneous coronary intervention between October 2016 and September 2018. With a median age of 56 years as a cutoff, the patients were divided into a younger group (≤56 years, n = 298) and an older group (>56 years, n = 290).

A total of 795 non-culprit plaques were found in 298 of the younger patients, whereas 858 non-culprit plaques were identified in 290 of the older patients. Fewer high-risk OCT plaques (15.8% vs. 23.1%; P = 0.025), as well as other structures (cholesterol crystals, P = 0.001; microchannels, P = 0.032; calcifications, P < 0.001; spotty calcifications, P < 0.001; large calcifications, P < 0.001; and thrombi, P = 0.001) were identified in younger patients than older patients, at the patient level. In addition, pancoronary vulnerability in younger patients was independently predicted by culprit plaque rupture {CLIMA-defined high-risk plaques (odds ratio [OR]: 3.179; 95% CI: 1.501 to 6.733; P = 0.003), non-culprit rupture (OR: 3.802; 95% CI: 1.604 to 9.014; P = 0.002), non-culprit thin-cap fibroatheroma (OR: 3.536; 95% CI: 2.051 to 6.094; P < 0.001)}, hypertension (OR: 1.920; 95% CI: 1.099 to 3.355; P = 0.022), and total cholesterol (OR: 1.094; 95% CI: 1.002 to 1.195; P = 0.045). In older patients with STEMI, the predictor was male sex (OR: 3.031; 95% CI: 1.352 to 6.795; P = 0.007).

Among patients with STEMI, younger patients had limited vulnerable plaque characteristics, and pancoronary vulnerability was associated with culprit plaque rupture, hypertension, and total cholesterol. In contrast, older patients had greater pancoronary vulnerability with the single predictor of male sex, thus suggesting that traditional risk factors have limited applicability in predicting pancoronary vulnerability in older patients.

Read More: https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2023.0082

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Tianyu Wu, Jiawei Zhao and Ming Zeng et al. Age-related Pancoronary Characteristics in Patients with ST-segment Elevation Myocardial Infarction. CVIA. 2024. Vol. 9(1). DOI: 10.15212/CVIA.2023.0082

Loading

Relationship between Serum Selenium Levels and Hypertension: Findings from the National Health and Nutrition Examination Survey, 2009–2018

Announcing a new article publication for Cardiovascular Innovations and Applications journal.

This study was aimed at evaluating the association between serum selenium (Se) levels and hypertension in American adults.

Data were extracted from the United States National Health and Nutrition Examination Survey (NHANES, 2009–2018). Multivariate logistic regression and subgroup analysis were conducted to examine associations between Se and hypertension.

Patients with hypertension had higher serum Se levels than healthy participants (P = 0.01017). After adjustment for demographic and health behaviors, serum Se levels were significantly associated with systolic blood pressure in women (OR = 0.014; 95% CI: 0.001–0.027; P = 0.04174). Serum Se levels were significantly associated with diastolic blood pressure (DBP) in both women and men. In subgroup analysis, serum Se levels were significantly associated with higher diastolic blood pressure (P for trend <0.001).

In summary, this analysis supports a nonlinear association between serum Se levels and the prevalence of hypertension, and higher serum Se levels were associated with higher DBP.

https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2023.0096

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Wang Lili and Guo Liwei. Relationship between Serum Selenium Levels and Hypertension: Findings from the National Health and Nutrition Examination Survey, 2009–2018. CVIA. 2024. Vol. 9(1). DOI: 10.15212/CVIA.2023.0096

Loading

Gut Microbiota and Vascular Diseases: An Update

Announcing a new article publication for Cardiovascular Innovations and Applications journal.

Vascular diseases, including atherosclerosis, aneurysms, and vascular calcification, are a leading cause of morbidity and mortality worldwide. In past decades, the gut microbiota has been found to be an indispensable population exerting effects on hosts under physiological and pathological conditions. Gut microbiota-derived metabolites, such as trimethylamine-N-oxide and short-chain fatty acids, mediate these effects by regulating vascular cells systematically. Translation of research knowledge to clinical scenarios has led to the development of new therapies including dietary interventions and metabolite inhibitors. This review describes recent advancements in understanding of the interplay between the gut microbiota and vascular dysfunction, and potential treatments for vascular diseases.

https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2023.0090

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Jiaqi Wu, Yuxuan Li and Peipei Yang et al. Gut Microbiota and Vascular Diseases: An Update. CVIA. 2024. Vol. 9(1). DOI: 10.15212/CVIA.2023.0090

Loading

Liver Fibrosis Scores as Predictors of Long-term Outcomes in Patients with ST-segment Elevation Myocardial Infarction

Announcing a new article publication for Cardiovascular Innovations and Applications journal.

Liver fibrosis scores (LFSs) are novel tools for predicting cardiovascular events in patients with coronary artery disease. This study was aimed at examining the prognostic value of LFSs in patients with ST-segment elevation myocardial infarction (STEMI).

Between 2015 and 2019, 866 patients diagnosed with STEMI were consecutively enrolled. The definition of major cardiovascular events (MACEs) was all-cause death, nonfatal myocardial infarction, nonfatal ischemic stroke, and acute limb ischemia. The authors of this article evaluated the predictive values of LFSs for MACEs with receiver operating characteristic (ROC) curve and restricted cubic spline (RCS) analysis. Kaplan-Meier (K-M) analysis was conducted to explore the relationship between LFSs and MACEs.

During a median follow-up of 4 years, 155 MACEs were observed. K-M analysis of MACEs revealed significantly lower event-free survival rates in patients with intermediate or high, rather than low, NFS, FIB-4, BARD, and Forns scores. The multivariable-adjusted hazard ratios (95% CI) for MACEs in patients with high versus low risk scores were 1.343 (0.822–2.197) for NFS, 1.922 (1.085–3.405) for FIB-4, 2.395 (1.115–5.142) for BARD, and 2.271 (1.250–4.125) for Forns. The ROC curve indicated that the predictive ability for MACEs was non significantly improved by addition of the NFS (AUC = 0.7274), FIB-4 (AUC = 0.7199), BARD (AUC = 0.7235), and Forns (AUC = 0.7376) scores into the basic model (AUC = 0.7181). RCS revealed a tendency toward a nonlinear positive association of MACEs with NFS, FIB-4, and particularly Forns scores.

LFSs have potential utility for predicting adverse outcomes in patients with STEMI, thus indicating the importance of managing metabolic dysregulation.

https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2023.0095

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Longyang Zhu, Yinong Chen and Qing Li et al. Liver Fibrosis Scores as Predictors of Long-term Outcomes in Patients with ST-segment Elevation Myocardial Infarction. CVIA. 2024. Vol. 9(1). DOI: 10.15212/CVIA.2023.0095

Loading

Rapid Plaque Progression in a Patient with Non-ST-Segment Elevation Acute Coronary Syndrome

Announcing a new article publication for Cardiovascular Innovations and Applications journal.    Acute coronary syndrome (ACS), diagnosed by optical coherence tomography (OCT), is caused primarily by plaque rupture, plaque erosion, and calcified nodules. Plaque erosion is more common in patients with non-ST-segment elevation myocardial infarction than ST-segment elevation myocardial infarction. This study reports the details of a case of ACS caused by massive thrombus formation due to plaque erosion. The factors associated with plaque erosion and thrombosis could not be confirmed on the basis of clinical examination findings and the physicians’ experience; therefore, the initial diagnosis of an ischemic event was replaced by a diagnosis of rapid plaque progression, as microscopically confirmed by OCT. Therefore, OCT examination must be performed for blurred or “rapidly progressing” lesions identified through angiography.

https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2023.0081

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Yachao Li et al. Rapid Plaque Progression in a Patient with Non-ST-Segment Elevation Acute Coronary Syndrome. CVIA. 2024. Vol. 9(1). DOI: 10.15212/CVIA.2023.0081

Loading

Clinical Significance of PCSK9 and Soluble P-selectin in Predicting Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome

Announcing a new article publication for Cardiovascular Innovations and Applications journal.  This study aimed at investigating the association of proprotein convertase subtilisin/kexin type 9 (PCSK9) with soluble P-selectin (sP-selectin), and their values in predicting major adverse cardiovascular events (MACE) at 1-year follow-up in patients with acute coronary syndrome (ACS) receiving dual antiplatelet therapy after primary percutaneous coronary intervention (PCI).

A total of 563 patients with ACS who underwent primary PCI were prospectively recruited from March 2020 to June 2021. The baseline levels of PCSK9, sP-selectin, and other platelet reactivity biomarkers were determined using enzyme-linked immunosorbent assays.

sP-selectin and ox-LDL levels significantly increased with increasing PCSK9 tertiles. High sP-selectin was associated with high PCSK9 levels, and PCSK9 was positively correlated with sP-selectin. Patients with both PCSK9 >17.4 ng/mL and sP-selectin >7.2 ng/mL had a significantly higher incidence of MACE than patients with lower levels. Multivariate analysis indicated that high sP-selectin and PCSK9 levels were independent risk factors for MACE, and the combination of PCSK9 and sP-selectin had better predictive value than each biomarker alone.

PCSK9 and sP-selectin may be potential predictive biomarkers for 1-year prognosis in patients with ACS after primary PCI.

Read More: https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2023.0087

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Yao Yao, Qining Qiu and Xiaoye Li et al. Clinical Significance of PCSK9 and Soluble P-selectin in Predicting Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome. CVIA. 2024. Vol. 9(1). DOI: 10.15212/CVIA.2023.0087

Loading